YUCAIPA, Calif., Jan. 21, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced that it has received several bulk purchases from various hospitals around the country. Columbia Memorial Hospital submitted a bulk purchase order for the new Oxyview Pulse Oximeter, and this is a strong indication of increased sales for 2010.
On January 14, 2010, the company received a purchase order from the Oregon based Columbia Memorial Hospital for the new Oxyview Pulse Oximeter. The Company has signed a contract with MediGroup to develop various GPO proposals and will move forward this quarter to align strategic national GPO contracts with the hospital industry.
“We look forward to working with Andy Klearman, President of MediGroup. This group was brought to the table by Charles Vorwaller, one of our Board of Directors. We expect to sell all of our products to hospitals, and MediGroup has the expertise to develop this distribution channel for the company,” stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
http://www.medigroup.com/
http://www.medox-oxyview.com/
http://www.oxyviewnasalcannula.com/AboutUs.html
http://www.ingen-tech.com/
About Ingen:
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company has domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the Oxyview Nasal Cannula was introduced as the world’s first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced the Oxyview Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Contact:
Ingen Technologies, Inc. Jeff Morgan 909-790-7180 info@ingen-tech.com www.ingen-tech.com
